Wave Life Sciences Announces Approval of First Clinical Trial Application for Restoraation-2 Trial of Wve-006 in Individuals With Alpha-1 Antitrypsin Deficiency (Aatd)
Wave Life Sciences宣佈批准了針對α-1抗胰蛋白酶缺乏症(Aatd)患者進行Wve-006的Restora-2試驗的首份臨床試驗申請
Wave Life Sciences Announces Approval of First Clinical Trial Application for Restoraation-2 Trial of Wve-006 in Individuals With Alpha-1 Antitrypsin Deficiency (Aatd)
Wave Life Sciences宣佈批准了針對α-1抗胰蛋白酶缺乏症(Aatd)患者進行Wve-006的Restora-2試驗的首份臨床試驗申請
使用瀏覽器的分享功能,分享給你的好友吧